Amgen Inc. (AMGN) Financial Statements (2024 and earlier)

Company Profile

Business Address ONE AMGEN CENTER DRIVE
THOUSAND OAKS, CA 91320
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments9,3058,03710,6478,91129,30441,678
Cash and cash equivalents7,6297,9896,2666,0376,9453,800
Short-term investments 1,676484,3812,87422,35937,878
Receivables5,5634,8954,5254,0573,5803,237
Inventory, net of allowances, customer advances and progress billings4,9304,0863,8933,5842,9402,834
Inventory4,9304,0863,8933,5842,9402,834
Other current assets2,3882,3672,0791,8881,7941,727
Total current assets:22,18619,38521,14418,44037,61849,476
Noncurrent Assets
Property, plant and equipment5,4275,1844,8894,9284,9584,989
Intangible assets, net (including goodwill)31,60930,07231,27634,11622,14223,370
Goodwill15,52914,89014,68914,70314,69914,761
Intangible assets, net (excluding goodwill)16,08015,18216,58719,4137,4438,609
Other noncurrent assets5,8996,5245,6392,2231,6982,119
Total noncurrent assets:42,93541,78041,80441,26728,79830,478
TOTAL ASSETS:65,12161,16562,94859,70766,41679,954
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities14,09612,09711,5629,8829,0697,868
Accounts payable1,5721,3661,4211,3711,2071,352
Accrued liabilities12,52410,73110,1418,5117,8626,516
Debt1,59187912,9534,4191,152
Total current liabilities:15,68712,18411,65312,83513,4889,020
Noncurrent Liabilities
Long-term debt and lease obligation37,35433,22232,89527,33829,51034,190
Long-term debt, excluding current maturities37,35433,22232,89526,95029,51034,190
Liabilities, other than long-term debt8,4199,0598,9919,64310,91811,503
Deferred tax liabilities, net8641,166
Deferred income tax liabilities    
Liability for uncertainty in income taxes5,7576,5946,9688,0378,7709,099
Other liabilities2,6622,4652,0231,6061,2841,238
Operating lease, liability    388
Total noncurrent liabilities:45,77342,28141,88636,98140,42845,693
Total liabilities:61,46054,46553,53949,81653,91654,713
Equity
Equity, attributable to parent, including:3,6616,7009,4099,67312,50025,241
Accumulated other comprehensive loss(231)(796)(985)(528)(769)(679)
Accumulated deficit(28,622)(24,600)(21,408)(21,330)(17,977)(5,072)
Other undisclosed equity, attributable to parent32,51432,09631,80231,53131,24630,992
Total equity:3,6616,7009,4099,67312,50025,241
Other undisclosed liabilities and equity    218  
TOTAL LIABILITIES AND EQUITY:65,12161,16562,94859,70766,41679,954

Income Statement (P&L) ($ in millions)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues26,32325,97925,42423,36223,74722,849
Revenue, net22,849
Cost of revenue
(Cost of Goods and Services Sold)
(6,406)(6,454)(6,159)(4,356)(4,101)(4,069)
Gross profit:19,91719,52519,26519,00619,64618,780
Operating expenses(10,351)(11,886)(10,126)(9,332)(9,383)(8,807)
Operating income:9,5667,6399,1399,67410,2639,973
Nonoperating income (expense)(814)259256753674928
Investment income, nonoperating     172
Interest and debt expense(1,406)(1,197)(1,262)(1,289)(1,392)(1,304)
Income from continuing operations before equity method investments, income taxes:7,3466,7018,1339,1389,5459,597
Loss from equity method investments      
Other undisclosed income from continuing operations before income taxes      
Income from continuing operations before income taxes:7,3466,7018,1339,1389,5459,597
Income tax expense(794)(808)(869)(1,296)(1,151)(7,618)
Income from continuing operations:6,5525,8937,2647,8428,3941,979
Income before gain (loss) on sale of properties:5,8937,2647,8428,3941,979
Net income available to common stockholders, diluted:6,5525,8937,2647,8428,3941,979

Comprehensive Income ($ in millions)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income:6,5525,8937,2647,8428,3941,979
Other comprehensive income (loss)565189(457)241(81)(208)
Comprehensive income, net of tax, attributable to parent:7,1176,0826,8078,0838,3131,771

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: